Cell Source, Inc.: 10-Q filed 2023-11-09

Name: Cell Source, Inc.: 10-Q filed 2023-11-09
Creator: Cell Source, Inc.

What Cell Source, Inc. reported in its quarterly report filed 2023-11-09 (fiscal Q3 2023): 21 published measures, 71 facts as tagged in accession 0001493152-23-040079.

This filing

Form: 10-Q (quarterly report)
Filed: 2023-11-09
Fiscal period: fiscal Q3 2023
Accession: 0001493152-23-040079 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2023-09-30	248,357	USD
At 2022-12-31	409,845	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2023-09-30	16,278,504	USD
At 2022-12-31	13,043,740	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2023-09-30	-16,030,147	USD
At 2023-06-30	-14,945,759	USD
At 2023-03-31	-14,219,717	USD
At 2022-12-31	-12,633,895	USD
At 2022-09-30	-11,953,970	USD
At 2022-06-30	-10,766,559	USD
At 2022-03-31	-9,997,117	USD
At 2021-12-31	-9,826,135	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-1,338,138	USD	92
2023-01-01 to 2023-09-30	-4,271,309	USD	273
2023-04-01 to 2023-06-30	-1,241,604	USD	91
2023-01-01 to 2023-03-31	-1,691,567	USD	90
2022-07-01 to 2022-09-30	-1,252,306	USD	92
2022-01-01 to 2022-09-30	-3,830,475	USD	273
2022-04-01 to 2022-06-30	-1,285,594	USD	91
2022-01-01 to 2022-03-31	-1,292,575	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	-1,625,601	USD	273
2022-01-01 to 2022-09-30	-2,415,411	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	1,405,518	USD	273
2022-01-01 to 2022-09-30	2,388,256	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2023-09-30	-40,617,485	USD
At 2022-12-31	-36,346,176	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	38,191,731	shares	92
2023-01-01 to 2023-09-30	37,492,478	shares	273
2022-07-01 to 2022-09-30	35,240,745	shares	92
2022-01-01 to 2022-09-30	34,696,011	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	38,191,731	shares	92
2023-01-01 to 2023-09-30	37,492,478	shares	273
2022-07-01 to 2022-09-30	35,240,745	shares	92
2022-01-01 to 2022-09-30	34,696,011	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-0.04	USD/shares	92
2023-01-01 to 2023-09-30	-0.14	USD/shares	273
2022-07-01 to 2022-09-30	-0.04	USD/shares	92
2022-01-01 to 2022-09-30	-0.14	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-0.04	USD/shares	92
2023-01-01 to 2023-09-30	-0.14	USD/shares	273
2022-07-01 to 2022-09-30	-0.04	USD/shares	92
2022-01-01 to 2022-09-30	-0.14	USD/shares	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-995,380	USD	92
2023-01-01 to 2023-09-30	-3,316,394	USD	273
2022-07-01 to 2022-09-30	-1,016,043	USD	92
2022-01-01 to 2022-09-30	-3,102,592	USD	273

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2023-09-30	1,580,863	USD
At 2022-12-31	680,325	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	995,380	USD	92
2023-01-01 to 2023-09-30	3,316,394	USD	273
2022-07-01 to 2022-09-30	1,016,043	USD	92
2022-01-01 to 2022-09-30	3,102,592	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2023-09-30	38,495,617	shares
At 2022-12-31	36,081,758	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2023-09-30	24,546,969	USD
At 2022-12-31	23,674,354	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-1,647,288	USD	92
2023-01-01 to 2023-09-30	-5,178,825	USD	273
2022-07-01 to 2022-09-30	-1,552,133	USD	92
2022-01-01 to 2022-09-30	-4,700,190	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	480,875	USD	92
2023-01-01 to 2023-09-30	2,097,801	USD	273
2022-07-01 to 2022-09-30	533,538	USD	92
2022-01-01 to 2022-09-30	1,571,572	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-342,758	USD	92
2023-01-01 to 2023-09-30	-954,915	USD	273
2022-07-01 to 2022-09-30	-236,263	USD	92
2022-01-01 to 2022-09-30	-727,883	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	949	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	900,538	USD	273
2022-01-01 to 2022-09-30	451,179	USD	273

Inspect the source

Entity: Cell Source, Inc. / CIK 0001569340
Captured: 2026-09-20T09:20:59.488Z
SEC response SHA-256: a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))